Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02550093 · ClinicalTrials.gov registry record · Phase 4
The Effect of Intranasal Oxytocin on Pain Sensitivity and Threshold
A Phase 4 study, sponsored by Northwestern University.
- Completed
- Registry status
- Phase 4
- Development phase
- 20
- Enrollment target
NCT02550093 is a Phase 4 study that has completed, run by Northwestern University. The registered enrollment target is 20 participants.
The verdict
NCT02550093, a Phase 4 study, has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 20 participants
- Enrollment target
Study Summary
Oxytocin is neurohypophysial peptide that acts mainly as a neuromodulator in the brain.The vast majority of basic science studies suggested a large effect of oxytocin in minimizing acute pain.Few studies have demonstrated an association between plasma levels of oxytocin and pain in humans. Since addictive properties of oxytocin have not been described, the drug may have important application in the management of acute and chronic pain. No studies have examined the effect of intranasal oxytocin on pain sensitivity and threshold.
Interventions
- PROCEDURE Intervention 1
- BEHAVIORAL Washout Period
- PROCEDURE Intervention 2
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2015-04 |
| Est. Completion | 2016-11 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02550093
The ClinicalTrials.gov registry entry for NCT02550093 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Intervention 1 is the first listed.
NCT02550093 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02550093 about?
NCT02550093 is a clinical study titled "The Effect of Intranasal Oxytocin on Pain Sensitivity and Threshold". Oxytocin is neurohypophysial peptide that acts mainly as a neuromodulator in the brain.The vast majority of basic science studies suggested a large effect of oxytocin in minimizing acute pain.Few studies have demonstrated an association between plasma levels of oxytocin and pain in humans. Since add...
What is the current status of trial NCT02550093?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 20 participants. The study started on 2015-04. Estimated completion is 2016-11.
What interventions are being tested in trial NCT02550093?
The interventions under investigation include: Intervention 1 (PROCEDURE), Washout Period (BEHAVIORAL), Intervention 2 (PROCEDURE).
Who is sponsoring clinical trial NCT02550093?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.